Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 1,196,980 | 1,162,801 | 1,102,321 | 1,122,057 | 1,116,898 |
| Cost of Goods | 504,199 | 515,867 | 502,261 | 504,672 | 499,146 |
| Gross Profit | 692,781 | 646,934 | 600,060 | 617,385 | 617,752 |
| Operating Expenses | 318,396 | 372,707 | 311,324 | 342,790 | 317,227 |
| Operating Income | 374,584 | 275,094 | 288,997 | 275,267 | 300,671 |
| Interest Expense | 11,026 | 13,805 | 14,957 | 14,943 | 14,964 |
| Other Income | 11,863 | -1,835 | -1,849 | 16,478 | 3,671 |
| Pre-tax Income | 375,421 | 259,454 | 272,191 | 276,802 | 289,378 |
| Income Tax | 74,929 | 50,654 | 52,769 | 47,138 | 56,878 |
| Net Income Continuous | 300,492 | 208,800 | 219,422 | 229,664 | 232,500 |
| Net Income | $300,492 | $208,800 | $219,422 | $229,664 | $232,500 |
| EPS Basic Total Ops | 2.04 | 1.42 | 1.49 | 1.57 | 1.58 |
| EPS Basic Continuous Ops | 2.04 | 1.42 | 1.49 | 1.56 | 1.58 |
| EPS Diluted Total Ops | 2.04 | 1.42 | 1.49 | 1.55 | 1.58 |
| EPS Diluted Continuous Ops | 2.04 | 1.42 | 1.49 | 1.55 | 1.58 |
| EPS Diluted Before Non-Recurring Items | N/A | 1.88 | 1.64 | 1.60 | 1.68 |
| EBITDA(a) | $429,226 | $328,464 | $342,439 | $330,466 | $353,461 |